Name | Value |
---|---|
Revenues | 691.7M |
Cost of Revenue | 306.2M |
Gross Profit | 385.5M |
Operating Expense | 284.0M |
Operating I/L | 101.5M |
Other Income/Expense | 0.9M |
Interest Income | 20.5M |
Pretax | 86.7M |
Income Tax Expense | 14.1M |
Net Income/Loss | 79.1M |
Revvity, Inc. operates in the diagnostics, life sciences, and applied services markets, offering instruments, reagents, informatics, software, and detection technologies for life sciences research, contract research, laboratory services, and environmental analysis. It also provides diagnostic instruments, reagents, and software for genetic disorder and infectious disease testing. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies.